Detalhe da pesquisa
1.
Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases.
J Med Chem
; 63(11): 5697-5722, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073845
2.
Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.
J Med Chem
; 62(9): 4656-4668, 2019 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995036
3.
Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit.
SLAS Discov
; 22(10): 1239-1245, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787579
4.
Long-acting protein drugs for the treatment of ocular diseases.
Nat Commun
; 8: 14837, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28332616